Developing services for long COVID: lessons from a study of wounded healers.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
Jan 2021
Historique:
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 4 2 2021
Statut: ppublish

Résumé

Persistent symptoms lasting longer than 3 weeks are thought to affect 10-20% of patients following SARS-CoV-2 infection. No formal guidelines exist in the UK for treating patients with long COVID and services are sporadic and variable, although additional funding is promised for their development.In this study, narrative interviews and focus groups are used to explore the lived experience of 43 healthcare professionals with long COVID. These individuals see the healthcare system from both professional and patient perspectives, thus represent an important wealth of expertise to inform service design.We present a set of co-designed quality standards, highlighting equity and ease of access, minimal patient care burden, clinical responsibility, a multidisciplinary and evidence-based approach, and patient involvement; and we apply these to propose a potential care pathway model that could be adapted and translated to improve care of patients long COVID.

Identifiants

pubmed: 33479069
pii: 21/1/59
doi: 10.7861/clinmed.2020-0962
pmc: PMC7850205
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-65

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© Royal College of Physicians 2021. All rights reserved.

Références

BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Thorax. 2020 Dec 3;:
pubmed: 33273028
BMC Health Serv Res. 2018 Sep 17;18(1):719
pubmed: 30223847
BMJ. 2004 Oct 30;329(7473):1013
pubmed: 15514347
J Fam Pract. 2004 Apr;53(4):299-306
pubmed: 15068775
JAMA. 2020 Oct 5;:
pubmed: 33031513
Br J Gen Pract. 2009 Nov;59(568):811-8
pubmed: 19861026
BMC Med. 2018 Jun 20;16(1):95
pubmed: 29921272
BMJ. 2020 Sep 15;370:m3565
pubmed: 32933949
BMC Health Serv Res. 2020 Dec 20;20(1):1144
pubmed: 33342437
Cochrane Database Syst Rev. 2017 Feb 23;2:CD004910
pubmed: 28230899
Int J Emerg Med. 2020 Jul 20;13(1):40
pubmed: 32689925
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910

Auteurs

Emma Ladds (E)

Nuffield Department of Primary Care Health Sciences, Oxford, UK e.ladds@nhs.net.

Alex Rushforth (A)

Nuffield Department of Primary Care Health Sciences, Oxford, UK.

Sietse Wieringa (S)

Nuffield Department of Primary Care Health Sciences, Oxford, UK.

Sharon Taylor (S)

Central and North West London NHS Foundation Trust, London, UK and Imperial College London, London, UK.

Clare Rayner (C)

independent occupational physician, Manchester, UK.

Laiba Husain (L)

Nuffield Department of Primary Care Health Sciences, Oxford, UK.

Trisha Greenhalgh (T)

Nuffield Department of Primary Care Health Sciences, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH